Table 1 Associations between clinically pathological characteristics and ZEB1 expression
Variable | Number of patients | ZEB1 expression | P value | |
|---|---|---|---|---|
Positive | Negative | |||
N = 60 | n = 23 | n = 37 | ||
Age | Â | Â | Â | 0.288 |
  > 16 years | 30 (50.0%) | 14 (60.9%) | 16 (43.2%) |  |
  ≤ 16 years | 30 (50.0%) | 9 (39.1%) | 21 (56.8%) |  |
Gender | Â | Â | Â | 0.097 |
 Female | 25 (41.7%) | 6 (26.1%) | 19 (51.4%) |  |
 Male | 35 (58.3%) | 17 (73.9%) | 18 (48.6%) |  |
Relapse | Â | Â | Â | 0.004 |
 No | 45 (75.0%) | 12 (52.2%) | 33 (89.2%) |  |
 Yes | 15 (25.0%) | 11 (47.8%) | 4 (10.8%) |  |
Metastasis | Â | Â | Â | 0.013 |
 No | 39 (65.0%) | 10 (43.5%) | 29 (78.4%) |  |
 Yes | 21 (35.0%) | 13 (56.5%) | 8 (21.6%) |  |
TNM | Â | Â | Â | 0.025 |
 I | 22 (36.7%) | 13 (56.5%) | 9 (24.3%) |  |
 II/III | 38 (63.3%) | 10 (43.5%) | 28 (75.7%) |  |
Site | Â | Â | Â | 0.435 |
 Else | 9 (15.0%) | 5 (21.7%) | 4 (10.8%) |  |
 Femur/Tibia | 51 (85.0%) | 18 (78.3%) | 33 (89.2%) |  |
Size | Â | Â | Â | 0.288 |
  > 6 cm | 30 (50.0%) | 14 (60.9%) | 16 (43.2%) |  |
  ≤ 6 cm | 30 (50.0%) | 9 (39.1%) | 21 (56.8%) |  |